These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22378)

  • 1. Sulphasalazine rectal enemas: topical method of inducing remission of active ulcerative colitis affecting rectum and descending colon.
    Serebro H; Kay S; Javett S; Abrahams C
    Br Med J; 1977 Nov; 2(6097):1264. PubMed ID: 22378
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial.
    Palmer KR; Goepel JR; Holdsworth CD
    Br Med J (Clin Res Ed); 1981 May; 282(6276):1571-3. PubMed ID: 6113021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-ASA enema versus oral sulphasalazine in maintaining remission in ulcerative colitis.
    Andreoli A; Spinella S; Levenstein S; Prantera C
    Ital J Gastroenterol; 1994 Apr; 26(3):121-5. PubMed ID: 7914759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphasalazine retention enemas in ulcerative colitis.
    Serebro HA; Kay S
    Br Med J (Clin Res Ed); 1981 Jul; 283(6284):144-5. PubMed ID: 6114768
    [No Abstract]   [Full Text] [Related]  

  • 5. Retrograde colonic spread of sulphasalazine enemas.
    Kruis W; Büll U; Eisenburg J; Paumgartner G
    Scand J Gastroenterol; 1982 Oct; 17(7):933-8. PubMed ID: 6130596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine-induced exacerbation of ulcerative colitis.
    Schwartz AG; Targan SR; Saxon A; Weinstein WM
    N Engl J Med; 1982 Feb; 306(7):409-12. PubMed ID: 6120459
    [No Abstract]   [Full Text] [Related]  

  • 7. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
    Frühmorgen P; Demling L
    Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An experiment to determine the active therapeutic moiety of sulphasalazine.
    Azad Khan AK; Piris J; Truelove SC
    Lancet; 1977 Oct; 2(8044):892-5. PubMed ID: 72239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of sulphasalazine and sulphapyridine after rectal and oral administration to patients with ulcerative colitis.
    Allgayer H; Kruis W; Eisenburg J; Paumgartner G
    Eur J Clin Pharmacol; 1984; 26(2):275-7. PubMed ID: 6144549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sulfasalazine enema in acute left-sided ulcerative colitis (author's transl)].
    Frimberger E; Frühmorgen P; Kühner W; Ottenjann R
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1233-5. PubMed ID: 6108506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and early diagnosis of cancer in the rectal stump of ulcerative colitis patients after colectomy and topical treatment.
    Trabucchi E; Baratti C; Centemero A; Rizzitelli E; Colombo R; Siardi C; Mariscotti C; Ferla G; Montorsi W
    Int J Clin Pharmacol Res; 1987; 7(2):157-64. PubMed ID: 2884192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical picture and therapy of nonspecific ulcerative proctitis (author's transl)].
    Schütze K; Hentschel E
    Wien Med Wochenschr; 1982 Feb; 132(4):91-3. PubMed ID: 6123196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rectal effect of salazopyrine in ulcerative colitis during a double-blind study].
    Schulz U; Hanke P; Seige K
    Wien Z Inn Med; 1973; 54(4):185-9. PubMed ID: 4148682
    [No Abstract]   [Full Text] [Related]  

  • 14. Further studies of sulphasalazine metabolism in the treatment of ulcerative colitis.
    Cowan GO; Das KM; Eastwood MA
    Br Med J; 1977 Oct; 2(6094):1057-9. PubMed ID: 21720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of disodium cromoglycate and sulphasalazine as maintenance therapy for ulcerative colitis.
    Willoughby CP; Heyworth MF; Piris J; Truelove SC
    Lancet; 1979 Jan; 1(8108):119-22. PubMed ID: 84148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial comparing olsalazine and sulphasalazine for the maintenance treatment of ulcerative colitis.
    Ireland A; Mason CH; Jewell DP
    Gut; 1988 Jun; 29(6):835-7. PubMed ID: 2898422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis.
    Campieri M; Gionchetti P; Belluzzi A; Brignola C; Tampieri M; Iannone P; Miglioli M; Barbara L
    Gut; 1991 Aug; 32(8):929-31. PubMed ID: 1885075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical salicylate therapy (4-ASA and 5-ASA enemas).
    Ginsberg AL
    Gastroenterol Clin North Am; 1989 Mar; 18(1):35-42. PubMed ID: 2563990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of serum concentrations of sulphasalazine and some of its metabolites after therapy by the oral or rectal route.
    Ashworth M; Arthur M; Turmer AD; Smith PR
    Pharmatherapeutica; 1984; 3(8):551-5. PubMed ID: 6142465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.